Please assess the completion status of the following clinical trial:

Trial Title: The Antidepressive Effect of rTMS as add-on to ECT

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Patients admitted to the Psychiatric Hospital of Aarhus~* Patients referred for ECT~* Age 18-80 years~* Moderate or severely depressed patients (ICD-10(DSM-IV)~* HAM-D score (17-item) ≥20 and/or Ham-D subscale ≥10.~Exclusion Criteria:~* Organic brain disease~* Epilepsy or disposition to epilepsy~* Metallic objects in chest or brain~* Cardiac pacemaker~* Somatic diseases associated with brain dysfunction~* Pregnancy~* Severe agitation or delirium~* Alcohol or drug dependence (ICD-10)~* Use of coercive measures~* The patient does not wish to participate

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- low frequency rTMS (Type: EXPERIMENTAL): Right prefrontal Low frequency (1 hz) repetitive transcranial magnetic stimulation, administered with 2 sessions each week
- Sham-rTMS (Type: SHAM_COMPARATOR): Sham right prefrontal rTMS 2 times a week

Based on this trial design, predict the completion outcome and termination type (if applicable).